We are live on ! Find out more
CA

CSM Advisors Portfolio holdings

AUM $4.07B
1-Year Est. Return 29.62%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+29.62%
3 Year Est. Return
+78.7%
5 Year Est. Return
+96.47%
10 Year Est. Return
AUM
$1.42B
AUM Growth
-$105M
Cap. Flow
-$127M
Cap. Flow %
-8.95%
Top 10 Hldgs %
41.52%
Holding
137
New
2
Increased
22
Reduced
64
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 11.84%
2 Financials 7.33%
3 Communication Services 6.97%
4 Consumer Discretionary 4.93%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
126
State Street SPDR S&P Biotech ETF
XBI
$9.62B
-316,300
Closed -$30M

Similar funds

CSM Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, CSM Advisors held 137 positions worth $1.42B, down 6.9% from $1.52B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

CSM Advisors withdrew a net $127M in Q2 2024, closing 10 positions and reducing 64 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $30M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Communication Services.

Against the trend, CSM Advisors opened a new position in iShares 20+ Year Treasury Bond ETF worth $25.9M.

  • CSM Advisors's largest Q2 2024 buy was iShares 20+ Year Treasury Bond ETF: 281,900 shares worth $25.9M.
  • CSM Advisors added most to iShares Russell 2000 ETF in Q2 2024, an estimated $26.1M increase.
  • CSM Advisors's biggest Q2 2024 reduction was Vanguard Russell 2000 ETF, cutting an estimated $4.19M.
  • CSM Advisors fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $30M.
  • CSM Advisors's ten largest holdings make up 42% of its $1.42B portfolio in Q2 2024.
  • CSM Advisors opened 2 new positions and closed 10 in Q2 2024.
  • CSM Advisors's portfolio value fell 6.9% quarter-over-quarter to $1.42B.

Based on CSM Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.